✦ LIBER ✦

What is the value of autologous bone marrow transplantation in the treatment of relapsed or resistant hodgkin's disease?

✍ Scribed by Andrew McMillan; Anthony Goldstone

Book ID: 113239366
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 601 KB
Volume: 15
Category: Article
ISSN: 0145-2126
DOI: 10.1016/0145-2126(91)90126-e

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dose intensification with autologous bon

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

✍ LINCH, P 📂 Article 📅 1993 🏛 The Lancet 🌐 English ⚖ 576 KB

Autologous bone marrow transplantation i

Autologous bone marrow transplantation in the treatment of poor prognosis non-Hodgkin's lymphomas

✍ Gorin, N.C.; Najman, A.; Douay, L.; Salmon, CH.; David, R.; Stachowiak, J.; Parl 📂 Article 📅 1984 🏛 Elsevier Science ⚖ 824 KB

Detection and significance of bone marro

Detection and significance of bone marrow infiltration at the time of autologous bone marrow transplantation in Hodgkin's disease

✍ R. Chopra; A. C. Wotherspoon; S. Blair; A. K. McMillan; W. Mills; A. K. Fielding 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB

Treatment of refractory and relapsed Hod

Treatment of refractory and relapsed Hodgkin's disease: Intensive chemotherapy and autologous bone marrow or peripheral blood stem cell support

✍ Hurd, David D. ;Haake, Robert J. ;Lasky, Larry C. ;Christiansen, Neal P. ;McGlav 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 719 KB

## Abstract Thirty‐three patients with recurrent or refractory Hodgkin's disease were treated with high‐dose cyclophosphamide, BCNU, and etoposide and supported with either autologous bone marrow or peripheral blood stem cells or both. Peripheral blood stem cells were comparable to bone marrow in s

Cost analysis and quality of life assess

Cost analysis and quality of life assessment comparing patients undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkin's lymphoma or Hodgkin's disease: a prospective randomised trial

✍ M van Agthoven; E Vellenga; W.E Fibbe; T Kingma; C.A Uyl-de Groot 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Autologous bone marrow transplantation (

Autologous bone marrow transplantation (ABMT) for non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD): The role of immunotherapy

✍ Nagler, A.; Drakos, P.; Akerstein, A.; Or, R.; Naparstek, E.; Kapelusnik, J.; Sl 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 180 KB